Head-to-head: meropenem/vaborbactam versus ceftazidime/avibactam in ICUs patients with KPC-producing K. pneumoniae infections– results from a retrospective multicentre study - Infection Infection - Meropenem/vaborbactam (M/V) and ceftazidime/avibactam (C/A) are considered key agents in treating KPC-producing Klebsiella pneumoniae (Kp) infections. We compared these two drugs in...

Just published in #Infection (#OpenAccess) likely the largest (retrospective multicenter) cohort so far comparing #Meropenem_Vaborbactam and #Ceftazidime_Avibactam for #KPC infections (#BSI and #pneumonia) in #ICU #patients.

link.springer.com/article/10.1...

#Italy #IDSky #PropensityScore